GAPDH Protein

GAPDH Protein

Overview

GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) is a 335-amino acid tetrameric enzyme (~37 kDa per subunit) encoded by the GAPDH gene on chromosome 12p13.31[@sirover2011]. While classically known as a glycolytic housekeeping enzyme, GAPDH has been extensively characterized as a moonlighting protein with critical non-glycolytic functions in [neurodegeneration](/diseases/neurodegeneration), including nuclear translocation–mediated [apoptosis](/mechanisms/apoptosis), [oxidative stress](/mechanisms/oxidative-stress) sensing, and direct interactions with disease-associated proteins such as [amyloid-beta](/proteins/amyloid-beta), [huntingtin](/proteins/huntingtin), and [alpha-synuclein](/proteins/alpha-synuclein)[@sirover2020]. Its dual identity as both an essential metabolic enzyme and a pro-death signal transducer makes it a nexus for understanding how energy metabolism and cell death intersect in neurodegenerative disease.

GAPDH Protein

Overview

GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) is a 335-amino acid tetrameric enzyme (~37 kDa per subunit) encoded by the GAPDH gene on chromosome 12p13.31[@sirover2011]. While classically known as a glycolytic housekeeping enzyme, GAPDH has been extensively characterized as a moonlighting protein with critical non-glycolytic functions in [neurodegeneration](/diseases/neurodegeneration), including nuclear translocation–mediated [apoptosis](/mechanisms/apoptosis), [oxidative stress](/mechanisms/oxidative-stress) sensing, and direct interactions with disease-associated proteins such as [amyloid-beta](/proteins/amyloid-beta), [huntingtin](/proteins/huntingtin), and [alpha-synuclein](/proteins/alpha-synuclein)[@sirover2020]. Its dual identity as both an essential metabolic enzyme and a pro-death signal transducer makes it a nexus for understanding how energy metabolism and cell death intersect in neurodegenerative disease.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">GAPDH</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Glyceraldehyde-3-Phosphate Dehydrogenase</td></tr>
<tr><td><strong>Gene</strong></td><td>[GAPDH](/genes/gapdh)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P04406](https://www.uniprot.org/uniprot/P04406)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>[1ZNQ](https://www.rcsb.org/structure/1ZNQ), [4WNC](https://www.rcsb.org/structure/4WNC)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~37 kDa (monomer); ~148 kDa (tetramer)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm; nucleus (under stress)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>GAPDH family (oxidoreductases)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">818 edges</a></td>
</tr>
</table>
</div>

Structure

GAPDH functions as a homotetramer, with each 335-residue subunit organized into two domains[@sirover2011]:

• NAD+-binding domain (residues 1–150): Contains a Rossmann fold that binds the NAD+ cofactor required for catalysis. The conserved Cys152 residue in the active site is the primary target of oxidative and nitrosative modification.
• Catalytic domain (residues 151–313): Harbors the substrate-binding site for glyceraldehyde-3-phosphate (G3P). The catalytic mechanism involves a thiohemiacetal intermediate at Cys152, followed by hydride transfer to NAD+.
• C-terminal tail (residues 314–335): Contributes to inter-subunit contacts and tetramer stability.

Normal Function

Glycolysis

GAPDH catalyzes the reversible oxidative phosphorylation of G3P to 1,3-bisphosphoglycerate (1,3-BPG), coupling substrate oxidation to NAD+ reduction. This sixth step of glycolysis is the only energy-conserving oxidation in the pathway and generates both NADH and a high-energy acyl-phosphate bond. In [neurons](/entities/neurons), which derive approximately 90% of their ATP from oxidative phosphorylation, GAPDH-generated NADH feeds the malate–aspartate shuttle to sustain [mitochondrial](/mechanisms/mitochondrial-dysfunction) electron transport[@sirover2011].

Non-glycolytic Functions

GAPDH moonlights in at least six additional cellular processes[@sirover2020]:

• DNA repair: Binds single-strand breaks and abasic sites; stimulates base excision repair (BER) through uracil-DNA glycosylase activation.
• mRNA regulation: Binds AU-rich elements in the 3′-UTR of transcripts encoding [BDNF](/proteins/bdnf-protein), [APP](/genes/app), and inflammatory cytokines, modulating their stability and translation.
• Membrane fusion: Associates with tubulin and promotes microtubule bundling; regulates vesicular trafficking between the ER and Golgi.
• Receptor-mediated endocytosis: Functions as a transferrin receptor-binding protein on macrophage surfaces.
• [Autophagy](/entities/autophagy): Under glucose starvation, GAPDH is phosphorylated by AMPK, facilitating its association with [Beclin-1](/proteins/becn1-protein) to initiate autophagosome formation.
• Gene transcription: In the nucleus, GAPDH acts as a transcriptional co-activator of histone genes (OCA-S complex) and participates in telomere maintenance.

Role in Neurodegeneration

The GAPDH–Siah1 Nuclear Translocation Cascade

The most direct pro-apoptotic function of GAPDH in neurodegeneration involves its interaction with the E3 ubiquitin ligase Siah1 (Seven in Absentia Homolog 1)[@hara2005]. Under conditions of oxidative or nitrosative stress:

This cascade has been demonstrated in cell models of [Huntington's disease](/diseases/huntingtons) (polyQ-expanded [huntingtin](/proteins/huntingtin) induces GAPDH nuclear accumulation), [Parkinson's disease](/diseases/parkinsons-disease) (MPTP/MPP+ drives GAPDH S-nitrosylation via nNOS), and [Alzheimer's disease](/diseases/alzheimers-disease) (Abeta oligomers increase GAPDH nuclear translocation in hippocampal neurons)[@burke1996][@mazzola2006].

Interaction with Disease-Associated Proteins

• Huntingtin: GAPDH binds polyQ-expanded huntingtin via a stretch of contiguous glutamine residues. The GAPDH–mutant huntingtin complex is preferentially sequestered in the nucleus, amplifying apoptotic signaling and depleting cytoplasmic GAPDH for glycolysis[@burke1996].
• Alpha-synuclein: GAPDH directly binds [alpha-synuclein](/proteins/alpha-synuclein) fibrils in vitro and colocalizes with Lewy bodies in post-mortem [PD](/diseases/parkinsons-disease) brain. Fibril binding inactivates GAPDH catalytic activity, contributing to the glycolytic deficit observed in PD substantia nigra[@tsuchiya2005].
• Amyloid-beta: Abeta peptides bind GAPDH and promote its aggregation into amyloid-like structures; GAPDH in turn accelerates Abeta fibrillization, creating a positive feedback loop relevant to [AD](/diseases/alzheimers-disease) plaque formation[@mazzola2006].
• Tau: GAPDH co-purifies with [tau](/proteins/tau) from human brain extracts, and oxidized GAPDH promotes tau phosphorylation at AD-relevant epitopes via [GSK-3beta](/proteins/gsk3b-protein) activation[@butterfield2010].

Oxidative Inactivation and Metabolic Failure

Because the active-site Cys152 is extremely sensitive to [reactive oxygen species](/entities/reactive-oxygen-species) (ROS), GAPDH is among the first glycolytic enzymes inactivated during [oxidative stress](/mechanisms/oxidative-stress). In AD, PD, and [ALS](/diseases/als), post-mortem studies show 30–50% reductions in GAPDH activity in affected brain regions, correlating with lactate accumulation and energy crisis[@mazzola2001]. Paradoxically, transient GAPDH inactivation diverts glycolytic flux through the pentose phosphate pathway, generating NADPH to combat oxidative damage — a protective metabolic switch that may be overwhelmed in chronic neurodegeneration.

Aggregation

Under severe oxidative stress, GAPDH forms high-molecular-weight aggregates with amyloid-like cross-beta structure. These aggregates are cytotoxic and have been identified in post-mortem AD [cortex](/brain-regions/cortex), where they colocalize with [neurofibrillary tangles](/mechanisms/neurofibrillary-tangles). GAPDH aggregation is accelerated by the same conditions — elevated NO, ROS, and metal ions — that drive disease protein misfolding[@nakajima2009].

Therapeutic Targeting

Deprenyl/Selegiline and Rasagiline

The MAO-B inhibitors [selegiline](/therapeutics/selegiline) (deprenyl) and [rasagiline](/therapeutics/rasagiline) were found to exert anti-apoptotic effects partly by blocking GAPDH–Siah1 binding and nuclear translocation, independent of their monoamine oxidase inhibition[@hara2005]. This "GAPDH-stabilizing" activity is thought to contribute to the neuroprotective signal observed in the DATATOP and ADAGIO trials in [PD](/diseases/parkinsons-disease).

CGP3466B (Omigapil)

CGP3466B is a deprenyl derivative specifically designed to block GAPDH nuclear translocation without MAO inhibitory activity. It showed neuroprotection in MPTP and SOD1-G93A mouse models but failed to reach efficacy endpoints in a Phase II/III [ALS](/diseases/als) trial, possibly due to advanced disease stage at enrollment[@miller2006].

R-(-)-Deprenyl Analogs

Structure-activity studies identified the propargylamino pharmacophore as the critical moiety for disrupting the GAPDH–Siah1 interface. Several next-generation propargylamines (TCH346, ladostigil) retain GAPDH-stabilizing activity while adding additional mechanisms (cholinesterase inhibition, iron chelation) relevant to [AD](/diseases/alzheimers-disease) and [PD](/diseases/parkinsons-disease).

Pathway & Interaction Diagram

Interactive diagram showing GAPDH key relationships in the SciDEX knowledge graph (15 connections shown).

See Also

• [Siah1 Protein](/proteins/siah1-protein)
• [Glycolysis in Neurodegeneration](/mechanisms/glycolysis-neurodegeneration)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Huntingtin](/proteins/huntingtin)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Rasagiline](/therapeutics/rasagiline)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)

External Links

• [UniProt: P04406](https://www.uniprot.org/uniprot/P04406)
• [PDB: 1ZNQ](https://www.rcsb.org/structure/1ZNQ)
• [OMIM: 138400](https://www.omim.org/entry/138400)
• [GeneCards: GAPDH](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAPDH)

References